camptothecin has been researched along with Abnormalities, Multiple in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenter, G; Chiang, SC; El-Khamisy, S; Kerzendorfer, C; O'Driscoll, M; Outwin, E; Raymond, FL; Schwartz, C; Turner, G; Whibley, A | 1 |
| Eckardt-Schupp, F; Friedl, AA; Jaspers, NG; Klein, B; Kraakman-van der Zwet, M; Lohman, PH; Midro, AT; Overkamp, WJ; Verhaegh, GW; Zdzienicka, MZ | 1 |
2 other study(ies) available for camptothecin and Abnormalities, Multiple
| Article | Year |
|---|---|
Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks.
Topics: Abnormalities, Multiple; Camptothecin; Cell Line; Cullin Proteins; DNA Damage; DNA Topoisomerases, Type I; Humans; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Syndrome; Ubiquitination | 2010 |
Immortalization and characterization of Nijmegen Breakage syndrome fibroblasts.
Topics: Abnormalities, Multiple; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Line; Cell Line, Transformed; Cell Survival; Cell Transformation, Viral; Child, Preschool; Chromosome Breakage; DNA; DNA Damage; DNA Repair; Etoposide; Fibroblasts; HeLa Cells; Humans; Mitomycin; Mutation; Syndrome; X-Rays | 1999 |